DE69027983D1 - Fusionsproteine bestehend aus TraTp und mindestens einem LHRH-Analog - Google Patents

Fusionsproteine bestehend aus TraTp und mindestens einem LHRH-Analog

Info

Publication number
DE69027983D1
DE69027983D1 DE69027983T DE69027983T DE69027983D1 DE 69027983 D1 DE69027983 D1 DE 69027983D1 DE 69027983 T DE69027983 T DE 69027983T DE 69027983 T DE69027983 T DE 69027983T DE 69027983 D1 DE69027983 D1 DE 69027983D1
Authority
DE
Germany
Prior art keywords
fusion proteins
tratp
pct
proteins consisting
lhrh analog
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69027983T
Other languages
English (en)
Other versions
DE69027983T2 (de
Inventor
Gregory Russell-Jones
Andrew Stewart
Con Tsonis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotech Australia Pty Ltd
Original Assignee
Biotech Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotech Australia Pty Ltd filed Critical Biotech Australia Pty Ltd
Publication of DE69027983D1 publication Critical patent/DE69027983D1/de
Application granted granted Critical
Publication of DE69027983T2 publication Critical patent/DE69027983T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/811—Drug, bio-affecting and body treating compositions involving sex selection or contraception
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
DE69027983T 1989-08-25 1990-08-24 Fusionsproteine bestehend aus TraTp und mindestens einem LHRH-Analog Expired - Fee Related DE69027983T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPJ597989 1989-08-25
PCT/AU1990/000373 WO1991002799A1 (en) 1989-08-25 1990-08-24 Fusion proteins

Publications (2)

Publication Number Publication Date
DE69027983D1 true DE69027983D1 (de) 1996-09-05
DE69027983T2 DE69027983T2 (de) 1997-03-20

Family

ID=3774139

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69027983T Expired - Fee Related DE69027983T2 (de) 1989-08-25 1990-08-24 Fusionsproteine bestehend aus TraTp und mindestens einem LHRH-Analog

Country Status (7)

Country Link
US (1) US5403586A (de)
EP (1) EP0446313B1 (de)
AT (1) ATE140972T1 (de)
CA (1) CA2040441C (de)
DE (1) DE69027983T2 (de)
NZ (1) NZ235038A (de)
WO (1) WO1991002799A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484592A (en) * 1989-03-23 1996-01-16 Stitching Centraal Diergeneeskundig Instituut Peptide, immunogenic composition and vaccine or medicinal preparation: a method of immunising a mammal against LHRH, and a method of improving the meat quality of pigs
CH683101A5 (de) * 1990-09-18 1994-01-14 Biotech Australia Pty Ltd T-Zellen-Epitope.
US5723129A (en) * 1991-10-16 1998-03-03 University Of Saskatchewan GnRH-leukotoxin chimeras
US5837268A (en) 1991-10-16 1998-11-17 University Of Saskatchewan GnRH-leukotoxin chimeras
ATE211654T1 (de) * 1992-09-16 2002-01-15 Univ Tennessee Res Corp Antigene des hybriden m-proteins und träger für gruppe a streptokokkenimpfstoff
US5688506A (en) * 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone
AUPO776897A0 (en) * 1997-07-09 1997-07-31 Csl Limited A method of achieving production gains in livestock and agents useful for same
AUPP807399A0 (en) 1999-01-08 1999-02-04 Csl Limited Improved immunogenic lhrh composition and methods relating thereto
ES2233284T3 (es) * 1999-02-17 2005-06-16 Pfizer Products Inc. Proteinas de fusion que comprenden portadores que pueden inducir una bdoble respuesta inmune.
US6838553B1 (en) * 1999-10-05 2005-01-04 Academia Sinica Peptide repeat immunogens
EP1303533A2 (de) * 2000-05-05 2003-04-23 Aphton Corporation Chimäre peptidimmunogene,deren herstellung und verwendung
CN102159240B (zh) 2008-09-17 2014-12-24 美国政府健康及人类服务部，疾病控制和预防中心 基于狂犬病毒的重组免疫避孕组合物及其使用方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR76959B (de) * 1981-01-02 1984-09-04 Univ New York State Res Found
US4624926A (en) * 1981-01-02 1986-11-25 The Research Foundation Of State University Of New York Novel cloning vehicles for polypeptide expression in microbial hosts
AU619443B2 (en) * 1986-04-21 1992-01-30 Bioenterprises Pty. Ltd. Immunopotentiation
CA1331355C (en) * 1986-04-21 1994-08-09 Bioenterprises Pty. Ltd Immunopotentation
NZ220932A (en) * 1986-07-03 1990-05-28 Victoria State Composition comprising an antigenic substance, such as lhrh, conjugated to at least two different carriers and method of immunological castration and spaying
AU7642387A (en) * 1986-07-03 1988-01-29 State Of Victoria, The Composition and method for immunological castration and spaying
AU602187B2 (en) * 1987-01-14 1990-10-04 Commonwealth Scientific And Industrial Research Organisation Anti-reproductive hormone
GB8713240D0 (en) * 1987-06-05 1987-07-08 Proteus Biotech Ltd Hormones

Also Published As

Publication number Publication date
EP0446313A1 (de) 1991-09-18
WO1991002799A1 (en) 1991-03-07
EP0446313A4 (en) 1992-08-19
CA2040441C (en) 1998-03-31
EP0446313B1 (de) 1996-07-31
ATE140972T1 (de) 1996-08-15
NZ235038A (en) 1992-09-25
CA2040441A1 (en) 1991-02-26
US5403586A (en) 1995-04-04
DE69027983T2 (de) 1997-03-20

Similar Documents

Publication Publication Date Title
DE69027983D1 (de) Fusionsproteine bestehend aus TraTp und mindestens einem LHRH-Analog
AU655915B2 (en) Cosmetic deodorants
ES2174855T3 (es) Metodos diagnosticos y composiciones farmaceuticas que se basan en proteinas notch y acidos nucleicos.
DK1378572T3 (da) BMP-11-sammensætninger
DE69331520T2 (de) Verwendung von bacillus thuringiensis-isolaten zur kontrolle von schädlingen aus der familie aphididae
ATE69727T1 (de) Zusammensetzung zur behandlung von an haemophilia- a-inhibitor leidenden kranken.
AU6070390A (en) Compositions derived from bi4v2o11
DE69607034D1 (de) Pcna bindende substanz
DE69220791D1 (de) Neue bacillus-thuringiensis isolate zur bekämpfung von akariden
DE59206628D1 (en) Expression signalpeptid-freier staphylokinasen
SE8801723D0 (sv) Fibronectin binding protein as well as its preparation
ATE148744T1 (de) Neue thrombininhibitorische proteine aus landblutegeln
GB2283974A (en) Allatostatins and their use
AU643773B2 (en) Growth hormone releasing factor analogs
AU4405689A (en) New limphokines, dna sequences coding for said limphokines and pharmaceutical compositions containing said limphokines

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee